greeksoup/ stock research

Healthstream Inc.: Q3 FY2025 earnings call

What management said about Q3 FY2025, from the documents filed with the SEC on 3 November 2025: press release. Guidance figures: 3 raised, 2 lowered, 3 kept. The quarter’s numbers.

Key takeaways

  • Record quarterly revenue: Third-quarter revenue rose 4.6% to $76.5 million from $73.1 million, a new company record for quarterly revenue. Source
  • Adjusted EBITDA hit record: Adjusted EBITDA rose 7.9% to $19.1 million from $17.7 million, which the CEO called record quarterly adjusted EBITDA. Source
  • Operating income rose on sublease: Operating income rose 16.5% to $7.6 million, attributed mainly to higher revenue, sublease income and lower stock-based compensation. Source
  • Platform spending lifted costs: Higher spending on platform and SaaS applications raised labor, cloud hosting, third-party software and capitalized software amortization costs. Source
  • Full-year ranges narrowed: Revenue, net income and adjusted EBITDA ranges narrowed with midpoints essentially unchanged; capital expenditures low end raised to $33.0 million. Source
  • Nine-month buybacks reached $25.0 million: The company repurchased 905,786 shares for $25.0 million over nine months, including 255,833 shares for $6.9 million in the third quarter. Source
  • Virsys12 bought for $13.0 million: Virsys12, LLC was acquired on October 8, 2025 for $13.0 million in cash, subject to a post-closing working capital adjustment. Source

“In the third quarter of 2025, HealthStream delivered record quarterly revenues of $76.5 million and record quarterly adjusted EBITDA of $19.1 million,”

Robert A. Frist, Jr., Chief Executive Officer, HealthStream

Guidance

AreaPeriodFigureAgainst last quarter
Revenue SourceFull year 2025$299.5 - $301.5 millionKept
Net income SourceFull year 2025$20.3 - $21.5 millionKept
Adjusted EBITDA SourceFull year 2025$69.5 - $71.5 millionKept
Capital expenditures SourceFull year 2025$33.0 - $34.0 millionRaised from $31.0 to $34.0 million
Interest income SourceFull year 2025(3,300) - (3,400) in thousandsLowered from (3,300) - (3,500) in thousands
Income tax provision SourceFull year 20255,800 - 6,200 in thousandsRaised from 5,200 - 6,000 in thousands
Stock-based compensation expense SourceFull year 20253,500 - 3,700 in thousandsLowered from 4,000 - 4,300 in thousands
Depreciation and amortization SourceFull year 202543,100 - 43,400 in thousandsRaised from 43,000 - 43,200 in thousands

What changed from last quarter

  • Guidance raised: Full-year capital expenditures guidance raised at the low end, to $33.0 million from $31.0 million; the high end stayed at $34.0 million.
  • Guidance kept: Revenue, net income and adjusted EBITDA midpoints unchanged in substance; each range narrowed. Source
  • Guidance lowered: Full-year stock-based compensation expense range lowered to 3,500-3,700 thousand dollars from 4,000-4,300 thousand. Source
  • Guidance raised: Full-year income tax provision and depreciation and amortization ranges both raised. Source
  • Ended: The $25.0 million share repurchase program authorized May 8, 2025 is no longer in effect; the maximum amount was spent during the third quarter. Source
  • New: Virsys12 acquisition completed October 8, 2025, adding a provider data management suite for payers and health plans. Source

Quarterly results and growth drivers

  • Record quarterly revenue: Third-quarter revenue rose 4.6% to $76.5 million from $73.1 million, a new company record for quarterly revenue. Source
  • Subscription revenue up, services down: Subscription revenues rose $4.0 million, or 5.7%, while professional services revenues fell $0.6 million. Source
  • Adjusted EBITDA hit record: Adjusted EBITDA rose 7.9% to $19.1 million from $17.7 million, which the CEO called record quarterly adjusted EBITDA. Source
  • Operating income rose on sublease: Operating income rose 16.5% to $7.6 million, attributed mainly to higher revenue, sublease income and lower stock-based compensation. Source
  • Net income and EPS both higher: Net income rose 6.3% to $6.1 million; diluted EPS was $0.20 against $0.19. Source

Year-to-date results

  • Nine-month revenue up 3.2%: Revenue for the first nine months was $224.4 million, up 3.2%, and operating income was $17.8 million, up 7.4%. Source
  • Nine-month EPS higher: Diluted EPS was $0.52 for the nine months against $0.50, and net income rose to $15.8 million from $15.1 million. Source
  • Nine-month adjusted EBITDA up 4.6%: Adjusted EBITDA rose 4.6% to $52.9 million for the nine months, from $50.6 million a year earlier. Source

“We are excited that our hStream platform is starting to create new business and social network opportunities in connecting two constituencies: individual healthcare professionals and organizations that employ them.”

Robert A. Frist, Jr., Chief Executive Officer, HealthStream

Costs and expense drivers

  • Platform spending lifted costs: Higher spending on platform and SaaS applications raised labor, cloud hosting, third-party software and capitalized software amortization costs. Source
  • Cost of revenues rose $2.0 million: Cost of revenues, excluding depreciation and amortization, was $26.5 million against $24.5 million. Source
  • Sales and marketing up, G&A down: Sales and marketing rose $0.6 million to $12.1 million, while general and administrative fell $1.1 million to $7.3 million. Source
  • Amortization rose, total costs up: Depreciation and amortization rose $0.7 million to $10.8 million; total operating costs and expenses were $68.9 million. Source

Margins and profitability

  • Adjusted EBITDA margin about 25.0%: Derived from the reported figures, adjusted EBITDA was about 25.0% of revenue against 24.2% a year earlier. Source
  • Operating margin about 9.9%: Derived from the reported figures, operating income was about 9.9% of revenue against 8.9% a year earlier. Source
  • Interest income fell: Third-quarter interest income was $0.8 million against $1.0 million, and the income tax provision was $2.2 million against $1.8 million. Source

Demand, renewals and guidance basis

  • Full-year ranges narrowed: Revenue, net income and adjusted EBITDA ranges narrowed with midpoints essentially unchanged; capital expenditures low end raised to $33.0 million. Source
  • Guidance rests on renewals and new sales: Management said guidance reflects its assumptions about new sales and renewals. Source
  • Guidance excludes acquisitions and impairments: Guidance excludes future acquisitions or dispositions, fair-value changes in non-marketable equity investments, and impairment of long-lived assets. Source
  • Deferred revenue at $85.7 million: Current deferred revenue was $85.7 million at September 30, 2025, up from $84.2 million at December 31, 2024. Source
  • Receivables and unbilled amounts fell: Accounts and unbilled receivables were $33.7 million, down from $35.3 million at December 31, 2024. Source

Cash, balance sheet and capital spending

  • Cash and securities of $92.6 million: Cash, cash equivalents and marketable securities were $92.6 million at September 30, 2025, with no borrowed-money debt outstanding. Source
  • Operating cash flow up: Net cash from operating activities was $50.1 million for the nine months, against $46.5 million a year earlier. Source
  • Third-quarter capex $7.8 million: Capital expenditures in the third quarter were $7.8 million; nine-month purchases of property and equipment were $3.5 million and capitalized software payments $21.9 million. Source
  • Goodwill and intangibles declined: Goodwill and intangible assets were $237.0 million, down from $246.8 million at December 31, 2024. Source

Share repurchases and dividend

  • Nine-month buybacks reached $25.0 million: The company repurchased 905,786 shares for $25.0 million over nine months, including 255,833 shares for $6.9 million in the third quarter. Source
  • Quarterly dividend declared: Board declared a quarterly cash dividend of $0.031 per share, payable November 28, 2025 to holders of record on November 17, 2025. Source
  • Nine-month dividends per share rose: Dividends declared were $0.093 per share for the nine months, against $0.084 a year earlier. Source

Virsys12 acquisition

  • Virsys12 bought for $13.0 million: Virsys12, LLC was acquired on October 8, 2025 for $13.0 million in cash, subject to a post-closing working capital adjustment. Source
  • Target serves payers and health plans: Virsys12 offers payers and health plans a provider data management suite for onboarding, credentialing and network management. Source
  • Expands Network by HealthStream: The acquisition expands the existing provider data management and credentialing solution for payers and health plan enterprises. Source

Platform and credentialing positioning

  • Workforce ecosystem positioning: The company describes itself as the healthcare industry's largest ecosystem of platform-delivered workforce solutions. Source
  • HStream links professionals and employers: The CEO's hStream comment describes linking individual healthcare professionals with the organizations that employ them. Source
  • Network sits in Credentialing suite: Network by HealthStream, launched 14 months ago, is part of the broader Credentialing application suite. Source

Coming up, as management said on 3 November 2025

  • Virsys12 contingent payment over three years: Up to $4.0 million more in cash may be paid, contingent on Virsys12 performance over three years after closing, alongside the working capital adjustment. Source

Figures management reported

FigureReported
Subscription revenue Sourceup $4.0 million, or 5.7%, versus the third quarter of 2024

Risks management discussed

  • Operational: Investment in platform and SaaS applications raised labor, cloud hosting, third-party software and capitalized software amortization costs. Source
  • Demand: Management said guidance assumes expectations for new sales and renewals. Source

Earlier plans management reported on

  • Not stated: The second-quarter release said the program would be completed in July; the third-quarter release says the full amount was used in the quarter ended September 30.
  • Not stated: The board approved the November quarterly dividend under the company's existing dividend policy. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.